Therefore, our study aimed to investigate the role of tumor-specific T cells in bladder cancer immunotherapy by constructing TstcSig, consisting of five tumor-specific T cell-related genes: CD27, CACYBP, TIGIT, LCK, and VAMP5. This evidence concerns the gene CD27 and neoplasm.